Ark Therapeutics, Ltd.
Records under this name other than the patents Ark Therapeutics, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Ark Therapeutics, Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,829,785 | Nucleic acid application primers Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,421,084 | Stent Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,603,912 | Cancer therapy Formerly held Lapsed on the fee record Ended Mar 28, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 28, 2025 | From the USPTO record |
| US 8,003,679 | Use of Inhibitors of the Renin-Angiotensin System Formerly held Term ended Term ended Oct 6, 2022 · Medium confidence | Term ended | Term ended Oct 6, 2022 | Medium confidence |
| US 6,579,855 | Adenovirus-mediated gene therapy Formerly held Term ended Term ended Jun 25, 2021 · From the USPTO record | Term ended | Term ended Jun 25, 2021 | From the USPTO record |
| US 8,334,271 | Use of VEGF in the treatment of retarded fetal growth in pregnancy Formerly held Lapsed on the fee record Ended Dec 18, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 18, 2020 | From the USPTO record |
| US 8,227,606 | Arginine derivatives with NP-1 antagonistic activity Formerly held Lapsed on the fee record Ended Jul 24, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jul 24, 2020 | From the USPTO record |
| US 7,998,953 | Use of inhibitors of the renin-angiotensin system Formerly held Term ended Term ended Jun 6, 2020 · From the USPTO record | Term ended | Term ended Jun 6, 2020 | From the USPTO record |
| US 7,905,847 | Device for protecting wounds on limbs Formerly held Term ended Term ended May 19, 2020 · From the USPTO record | Term ended | Term ended May 19, 2020 | From the USPTO record |
| US 8,604,070 | Use of inhibitors of the renin-angiotensin system Formerly held Term ended Term ended Oct 19, 2018 · From the USPTO record | Term ended | Term ended Oct 19, 2018 | From the USPTO record |